Buying an insurance policy is going to be difficult in some cases for those who have not yet been vaccinated against the COVID-19 virus, according to experts.

With the monsoon setting in, vector-borne diseases are an added worry, even as we battle the covid-19 pandemic. Under the circumstances, purchasing health insurance against vector-borne diseases can make sense.

Some plans come with treatment procedure-related sublimits. "A sub-limit clause in a health insurance policy is a cap that the insurer places on the policyholder's expenses for a specific medical procedure. It is usually a predefined limit set by the insurer on the total claim amount for certain diseases or medical treatments," says Indraneel Chatterjee, Co-Founder RenewBuy.

There are instances in life when people miss paying the insurance premiums on time, due to various factors. The rising Covid scenario can be one such factor when people might forget to pay insurance premiums due to uncalled-for medical emergencies.

RenewBuy, one of India’s leading InsurTech companies, has raised US$ 45 million, in a series C funding round. This funding round has been led by an investment from Apis Growth Fund II, a private equity fund managed by Apis Partners LLP, a UK-based asset manager. RenewBuy's existing investors, Lok Capital and IIFL Wealth also participated in the fundraise.

RenewBuy, one of India's leading InsurTech companies, has raised $45m in a Series C funding round. This funding round was led by an investment from Apis Growth Fund II, a private equity fund managed by Apis Partners , a UK-based asset manager that supports growth-stage financial services and FinTech businesses. RenewBuy's existing investors, Lok Capital and IIFL Wealth also participated in the fundraise, according to a statement issued by the InsurTech company.

Insurtech company RenewBuy has raised $45 million in a Series C funding round. This round was led by an investment from APIS Growth Fund II, a private equity fund managed by the UK-based asset manager APIS Partners LLP. RenewBuy's existing investors - Lok Capital and IIFL Asset Management - also participated in the fund raise. Since the pandemic, there has been a significant increase in demand for insurance products. And through this period, RenewBuy claims it has accelerated its growth significantly.

Insurtech startup RenewBuy has raised $45 million (about Rs 320 crore) in a Series C funding round led by Apis Growth Fund II.

Driven by strong and growing demand for insurance products InsurTech firm RenewBuy has raised US$ 45 million in a series C funding round. This funding round has been led by an investment from Apis Growth Fund II, a private equity fund managed by Apis Partners LLP, a UK-based asset manager that supports growth stage financial services and financial technology businesses. Its existing investors, Lok Capital and IIFL Wealth also participated in the fundraise.

Insurtech startup has raised $45 million (about Rs 320 crore) in a Series C funding round led by Apis Growth Fund II, a fund managed by UK-based asset manager Apis Partners.